37 participants
VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-10-10
- Start Date:
- 2021-06-23
- Completion:
- 2024-07-23
Conditions
- Non-Hodgkin Lymphoma (NHL)
- Acute Myeloid Leukemia (AML)
- Multiple Myeloma (MM)
Interventions
- DRUG
No Results Yet